J&J’s Cardiovascular Unit: A Blueprint for Strategic Focus in Medtech Growth
Johnson & Johnson’s cardiovascular segment delivering double-digit growth in Q1 is no accident—it’s a direct result of a deliberate, well-executed strategic pivot towards higher-growth medical device markets. While many medtech…